Search - tctmd.com

Displaying 221 - 240 of 293

Sort: Relevancy | Date

News Industry News

Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients

February 21, 2012

News Industry News

Increased reimbursement of Self-Expanding drug-eluting stents in Germany now for all indications

February 07, 2012

News Industry News

STENTYS concludes clinical trial ahead of plan

January 31, 2012

News Industry News

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

January 15, 2012

News Industry News

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

December 19, 2011

News Industry News

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

December 07, 2011

News Industry News

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

November 21, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Industry News

Polymer-free drug eluting stents result in lower in-stent late loss

November 10, 2011

News Industry News

Paclitaxel-coated balloon angioplasty demonstrates superior results

November 10, 2011

News Industry News

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

November 10, 2011

News Industry News

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

November 10, 2011

News Industry News

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

November 10, 2011

News Industry News

Clinical trial establishes non-inferiority of drug-eluting stent with a bioabsorbable polymer

November 10, 2011

News Industry News

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

November 09, 2011

News Industry News

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

November 09, 2011

News Industry News

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

November 09, 2011

News Industry News

Low CV Event Rate Prompts Closure of Prasugrel Trial

November 09, 2011

News Industry News

Gilead Sciences, CRF commence Ranolazine trial to treat MACE

November 09, 2011

News Industry News

Coronary Thrombectomy in conjunction with primary percutaneous coronary intervention in patients with high thrombotic burden improves myocardial perfusion

November 09, 2011

Advertisement

Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients

Increased reimbursement of Self-Expanding drug-eluting stents in Germany now for all indications

STENTYS concludes clinical trial ahead of plan

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

Use of OrbusNeich’s Genous™ Stent in a Coronary Bifurcation Setting Is Feasible and Safe, with No Incidence of Late Stent Thrombosis and a Very Low Rate of Repeated Revascularization

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent

Boston Scientific Receives FDA Approval for PROMUS Element™ Plus Platinum Chromium Stent System

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Polymer-free drug eluting stents result in lower in-stent late loss

Paclitaxel-coated balloon angioplasty demonstrates superior results

Head-to-head comparison of two second generation drug-eluting coronary stents demonstrates non-inferiority

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

Clinical trial of a new dual therapy stent establishes non-inferiority compared to paclitaxel-eluting stent

Clinical trial establishes non-inferiority of drug-eluting stent with a bioabsorbable polymer

Use of drug-eluting balloons with bare metal stents do not show superiority over drug-eluting stents

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

OrbusNeich Introduces the Combo™ Dual Therapy Stent at TCT 2011

Low CV Event Rate Prompts Closure of Prasugrel Trial

Gilead Sciences, CRF commence Ranolazine trial to treat MACE

Coronary Thrombectomy in conjunction with primary percutaneous coronary intervention in patients with high thrombotic burden improves myocardial perfusion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content